BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1524 related articles for article (PubMed ID: 15054367)

  • 41. [How and when is topical treatment applied into the ear?].
    Hopsu E; Närkiö-Mäkelä M; Silvola J
    Duodecim; 2011; 127(14):1470-80. PubMed ID: 21888048
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Role of glucocorticoids in ototopical antibiotic-steroid preparations in the treatment of chronic suppurative otitis media.
    Indudharan R; Valuyeetham KA; Raju SS
    Arch Med Res; 2005; 36(2):154-8. PubMed ID: 15847949
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Assessment of acute otitis externa and otitis media with effusion performance measures in otolaryngology practices.
    Patel MM; Eisenberg L; Witsell D; Schulz KA
    Otolaryngol Head Neck Surg; 2008 Oct; 139(4):490-494. PubMed ID: 18922333
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Chronic otitis media after tympanostomy tube placement caused by Mycobacterium abscessus: a new clinical entity?
    Franklin DJ; Starke JR; Brady MT; Brown BA; Wallace RJ
    Am J Otol; 1994 May; 15(3):313-20. PubMed ID: 8579134
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Panel 7: Treatment and comparative effectiveness research.
    Marchisio P; Chonmaitree T; Leibovitz E; Lieberthal A; Lous J; Mandel E; McCormick D; Morris P; Ruohola A
    Otolaryngol Head Neck Surg; 2013 Apr; 148(4 Suppl):E102-21. PubMed ID: 23536528
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Infective causes of facial nerve paralysis.
    Makeham TP; Croxson GR; Coulson S
    Otol Neurotol; 2007 Jan; 28(1):100-3. PubMed ID: 17031324
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Microbiology of acute otitis media with tympanostomy tubes.
    Roland PS; Parry DA; Stroman DW
    Otolaryngol Head Neck Surg; 2005 Oct; 133(4):585-95. PubMed ID: 16213934
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Accuracy and patient perceived difficulty of utilizing ototopical antibiotic therapy.
    Selleck AM; Dedmon MM
    Am J Otolaryngol; 2021; 42(5):103130. PubMed ID: 34242952
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Clinicomicrobiologic evaluation of active tubotympanic type chronic suppurative otitis media.
    Khanna V; Chander J; Nagarkar NM; Dass A
    J Otolaryngol; 2000 Jun; 29(3):148-53. PubMed ID: 10883827
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Emergence of ciprofloxacin-resistant pseudomonas in chronic suppurative otitis media.
    Jang CH; Park SY
    Clin Otolaryngol Allied Sci; 2004 Aug; 29(4):321-3. PubMed ID: 15270816
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Usefulness of fenspiride in the treatment of acute otitis media in children].
    Zielnik-Jurkiewicz B; Jurkiewicz D
    Pol Merkur Lekarski; 2005 Jun; 18(108):624-8. PubMed ID: 16124370
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Initial impact of the acute otitis externa clinical practice guideline on clinical care.
    Bhattacharyya N; Kepnes LJ
    Otolaryngol Head Neck Surg; 2011 Sep; 145(3):414-7. PubMed ID: 21531870
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Ototoxicity of ear drops: a clinical perspective.
    Linder TE; Zwicky S; Brändle P
    Am J Otol; 1995 Sep; 16(5):653-7. PubMed ID: 8588672
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Change of external auditory canal pH in acute otitis externa.
    Kim JK; Cho JH
    Ann Otol Rhinol Laryngol; 2009 Nov; 118(11):769-72. PubMed ID: 19999361
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Current bacteriology of chronic otitis media with effusion: high rate of nosocomial infection and decreased antibiotic sensitivity.
    Jung H; Lee SK; Cha SH; Byun JY; Park MS; Yeo SG
    J Infect; 2009 Nov; 59(5):308-16. PubMed ID: 19715725
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Considerations on acute otitis externa for its optimized treatment].
    García Callejo FJ; Muñoz Martínez N; Achiques MT; Conill Tobías N; Montoro Elena MJ; Algarra JM
    Acta Otorrinolaringol Esp; 2009; 60(4):227-33. PubMed ID: 19814968
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Antimicrobial resistance of Pseudomonas aeruginosa from otorrhea of chronic suppurative otitis media patients.
    Lee SK; Lee MS; Jung SY; Byun JY; Park MS; Yeo SG
    Otolaryngol Head Neck Surg; 2010 Oct; 143(4):500-5. PubMed ID: 20869558
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Ototopical drops containing a novel antibacterial synthetic peptide: Safety and efficacy in adults with chronic suppurative otitis media.
    Peek NFAW; Nell MJ; Brand R; Jansen-Werkhoven T; van Hoogdalem EJ; Verrijk R; Vonk MJ; Wafelman AR; Valentijn ARPM; Frijns JHM; Hiemstra PS; Drijfhout JW; Nibbering PH; Grote JJ
    PLoS One; 2020; 15(4):e0231573. PubMed ID: 32287316
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Dexamethasone phosphate in antibiotic ear drops for the treatment of acute bacterial otitis externa.
    Mösges R; Schröder T; Baues CM; Sahin K
    Curr Med Res Opin; 2008 Aug; 24(8):2339-47. PubMed ID: 18606053
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Why are ototopical aminoglycosides still first-line therapy for chronic suppurative otitis media? A systematic review and discussion of aminoglycosides versus quinolones.
    Harris AS; Elhassan HA; Flook EP
    J Laryngol Otol; 2016 Jan; 130(1):2-7. PubMed ID: 26584651
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 77.